01.10.2000
Treatment of advanced, refractory breast cancer with alternating docetaxel and epirubicin/cyclophosphamide plus human granulocyte colony-stimulating factor
Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2000
Einloggen, um Zugang zu erhalten